Jump to content

jhaig

Members - Bounced Email
  • Posts

    199
  • Joined

  • Last visited

  • Country

    United States

About jhaig

  • Birthday 05/08/1969

Profile Information

  • Interests
    Softball
  • Biography
    Age 39
  • Location
    Upstate NY
  • Occupation
    Blood Bank Supervisor

Recent Profile Visitors

The recent visitors block is disabled and is not being shown to other users.

jhaig's Achievements

Community Regular

Community Regular (8/14)

  • First Post
  • Collaborator
  • Week One Done
  • One Month Later
  • One Year In

Recent Badges

13

Reputation

  1. I may do the same thing. I want to keep the gel cards and the 0.8% Ortho panels (I think the BioRad panel is a 3%?). I've validated all of the anti-sera, but I'm still considering the Biotestcell screening cells. What obstacles would there be if I switched to Biotest screening cells but kept the Ortho 0.8% ID panels?
  2. I'm going to begin a validation study on Bio-Rad's blood bank reagents and rare anti-seras and was wondering if anyone out there is currently either evaluating or using them. The pricing is what caught my eye at first, so now we're going to see how they stack up against our current company (Immucor).
  3. My question is .... what if the specimen was incorrectly drawn in the first place? It won't matter how many techs type it if it's the wrong patient. If you are a CAP blood bank, they may be moving towards two separate specimens at two separate draws not only being a recommendation, but a requirement. We have amended our retyping policy to include two draws at two separate times before transfusing any red cell products. If a redraw cannot be obtained, we give group O cells.
  4. I'm sure we won't even get a 'thank-you' to let us know we're appreciated.
  5. I'm in the process of updating my panel procedure (we use Ortho 0.8% panel A and B, with Immucor Panocell 10 as a backup) and I want to do rule outs on homozygous cells. I wan to use the following rules: rule out on 2 homozygous cells (preferred), 3 heterozygous cells, or a combination of 3 cells of the above. I need to tap into your collective wisdom and knowledge. Where are the holes in this thinking and what do I need to fix or re-think?
  6. I received a crossmatch order on a patient with a specific diagnosis and then had the acronym UNIVAC after it. Wondering if this was a diagnosis or a new piece of medical equipment, I called the floor and they told me it stood for "Unusually nasty infection, vultures are circling". I didn't know whether to laugh or not.
  7. I agree that there's no specific standard, but I'm referring to the AABB technical manual 15th ed, pg 455 "Many workers routinely attempt to determine the cause of a positive DAT when the patient has recevied transfusions within the previous 3 months". I just don't know how to adjust my protocol because I can't find any documentation to back me up. Is this something I can change based on my patient population or are there any specific guidelines to follow? The AABB manual also goes on to say that "antibody may appear as early as 7 to 10 days (but typically 2 weeks to several months)". That, to me, leaves a lot open to interpretation.
  8. According to AABB, you should perform a DAT on patients that have been transfused within the previous 3 months. Our reference lab will only do one if the transfusion had occured within the previous 30 days. I'm not 100% sure where they got the info to adopt this protocol, but is there any documentation out there that will let me change my protocol to 30 days rather than 3 months? Last time I checked 3 months was the accepted standard.
  9. Is anyone aware of any contraindications for reinfusing autologous donor units after they have received any types of radiographic dye? We had a patient yesterday that had a stress test prior to auto donation that received some type of radioactive isotope (either thallium with a half life of 72 hours or it was another dye that had a half life of 6 hours). Our pathologist said that since it was OK to infuse the dye into the patient to begin with, then the patient should be OK to receive his own blood back should he need it. Should I be concerned with the unit and quarantine it just to be safe? Or is it going to be OK to give back?
  10. Is it acceptable to use expired anti-sera as long as the QC gives acceptable results? Any regs to support/disprove this?
  11. Our issue all started when a female patient came to us for a prenatal type and screen. Up until this point we had done weak-D testing on all females of child-bearing age and we typed her as a weak-D positive. Well, of course, her hospital in Virginia said she was Rh-negative. Confusion ensued, and I decided that this was a headache I didn't want to have to deal with again:cool:
  12. We dropped all weak-D testing last year. We do not deliver babies here so there's no need to worry about testing neonates. No need to determine a weak-D status for any other testing that we perform here. If a transfusion recipient types as Rh-neg, they'll receive Rh-neg blood prducts anyway, so why confuse the patient by telling them they're really Rh pos? The only way they would know better is if they were a regular blood donor and were told they were weak-D pos by the donor center.
  13. Can I find these guidelines on-line or do I need to purchase them? (Oops, It's NY, I should know this already:cool:)
  14. It blows my mind to think that the BLOOD BANK should not be in the loop when it comes to providing BLOOD for surgery! It's like trying to fly a plane without having access to the weather report.
  15. We currently have a maximum surgical blood order schedule (MSBOS) in place in our facility and I'm in the process of updating it. Our med exec. committee seems to want to steer away from it, stating that the physician knows their patient better than the blood bank and will order blood products as they deem appropriate. Is having an MSBOS like ours a requirement from AABB or CAP? I can't seem to find anything specifically that requires us to have one. Or is it just one of those "good ideas" from the age of dinosaurs set up as a safety net for patient orders that may fall through? I'd like to ditch the whole thing if possible, but I have no ammo to back it up yet. Quite frankly, I'm not comfortable with ordering blood products on my own without getting in some kind of regulatory trouble. I'd just as soon leave it in the hands of the doctors while maintaining patient safety at the same time.
×
×
  • Create New...

Important Information

We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.